Ipratropium nebs, 0.5 mg, same frequency, are to be automatically substituted for the MDI.  If MDI therapy is to be continued per RT evaluation, convert to Umeclidinium (Incruse Ellipta)

Automatic substitution based on criteria specificed by P&T

Intubated and pediatric patients are excluded from this substitution

• Recent Citations via Medline (PubMed)
• FDA DRUG INFORMATION
• MICROMEDEX
• FDA Daily Med Package Inserts